Compute Oil Emerges as Kalshi Launches AI Power Bets
Kalshi unveils a new prediction market to price future GPU computing power, positioning compute oil as a key asset cl...
Which Is Better Retirement Funds Index Or Target Date
This piece analyzes whether retirement funds should favor index or target date options, emphasizing long-term planning and goal alignment.
26,209 articles
Vitalik Selling Ethereum Grabs Attention as Liquidity Shifts
Vitalik selling ethereum grabs attention in a thin market, but the bigger signal may be the Ethereum Foundation's mov...
Clark Howard’s Advice for Families Facing the $50K Loan Cap
Starting July 2026, the federal loan cap for professional programs changes how families fund education. Clark Howard’...
Salesforce Turbocharges Billion Stock Buyback with $25B Debt
Salesforce unveiled a record $25 billion accelerated share repurchase funded by debt as it posted quarterly results. ...
700% YTD Surge: How High Can SanDisk Rally Go in 2026?
SanDisk has surged to record highs, up 700% YTD, with AI-driven demand and supply constraints propelling the run. The...
Arrow Electronics Stock Sell: Buy or Sell After VP Dump?
When a senior executive sells thousands of shares, investors often jump to conclusions. This article breaks down what...
MVST Stock Down This Year After Inventory Hit, Wary on 2026 Prospects
Microvast’s Q4 2025 results trigger a sharp pullback in mvst stock down this year. A $32.5 million inventory impairme...
Cramer Says DoorDash Is a Buy Despite 30% Decline Today
Jim Cramer defies the pullback, urging investors to buy DoorDash despite a roughly 30% year-to-date drop. The call hi...
Pump.fun Offers Million Salary for Chief Legal Officer
Pump.fun has unveiled a record-setting compensation package for its Chief Legal Officer, signaling a competitive push...
Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Kalvista's (Kalv) Chief Development Insider Trade Watch
When a top executive sells shares after exercising options, markets take note. This deep dive breaks down Kalvista's ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status